What impact do DMTs have on disease progression?

In this video Marlo interviews Professor David Baker who is a Researcher. The interview was filmed by Stephanie

Video transcript

Polly asks Gavin why statins aren’t given to SPMSers even though they’ve been through Phase 2 clinical trials. At 01:02 she asks whether he’s hopeful that it might become a treatment. At 01:28 she asks about GPs prescribing statins for MS patients who request them.

MS Reporter: Polly

MS Expert: Gavin Giovannoni is a Professor of Neurology and Neuroscience and Trauma Centre Lead in the Blizard Institute at Barts and the Royal London. He splits his time between seeing patients and researching MS.

More videos about Which DMT category

Leave a Reply

Got a question? Ask an expert.
Join the Shift.ms communityclose